美股市场个股详情
BMRN 拜玛林制药
- 83.330
- +2.570+3.18%
收盘价 05/01 16:00 (美东)
- 83.420
- +0.090+0.11%
盘后 18:53 (美东)
158.23亿总市值78.61市盈率TTM
83.980最高价80.500最低价188.19万股成交量81.070今开80.760昨收1.55亿成交额1.00%换手率95.78市盈率(静)1.90亿总股本99.56052周最高3.12市净率157.01亿流通值76.02052周最低--股息TTM1.88亿流通股151.750历史最高--股息率TTM4.31%振幅3.570历史最低82.554平均价1股每手
关于拜玛林制药公司
拜玛林制药股份有限公司致力于为患有严重和危及生命的罕见疾病和医疗状况的人开发和商业化治疗。其管道产品包括valoccogene roxaparvovec, Vosoritide和BMN 307。
公司介绍
公司代码BMRN
公司名称拜玛林制药
上市日期1999/07/23
发行价格13.00
成立日期1997
CEOMr. Alexander Hardy
所属市场纳斯达克
员工数量3401
证券类型海外普通股
年结日12-31
公司地址770 Lindaro Street
城市San Rafael
省份加利福尼亚州
国家美国
邮编94901
电话1-415-506-6700
董事高管
- 姓名
- 职务
- 年薪
- Alexander Hardy
- Director, President and Chief Executive Officer
- 1787.52万
- Charles Greg Guyer
- Chief Technical Officer and Executive Vice President
- 570.11万
- Brian R. Mueller
- Executive Vice President and Chief Financial Officer
- 485.42万
- Jeffrey R. Ajer
- Executive Vice President and Chief Commercial Officer
- 507.04万
- Erin Burkhart
- Group Vice President and Chief Accounting Officer
- --
- G. Eric Davis
- Executive Vice President, Chief Legal Officer and Secretary
- --
- Richard A. Meier
- Chairman of the Board
- 51.54万
- Dr. Henry J. Fuchs,M.D.
- President, Worldwide Research and Development
- 966.08万
- Jean-Jacques Bienaime
- Director
- 2197.60万
- Robert J. Hombach
- Independent Director
- 48.69万
- Dr. Athena Countouriotis, M.D.
- Independent Director
- 21.34万
- Mark Joseph Enyedy
- Independent Director
- 21.34万
- Barbara W. Bodem
- Independent Director
- 21.34万
- Dr. V. Bryan Lawlis, PhD
- Independent Director
- 47.04万
- Dr. Willard H. Dere, M.D.
- Independent Director
- 48.04万
- Dr. Dennis J. Slamon, M.D.,PhD
- Independent Director
- 46.04万
- Elizabeth McKee Anderson, M.B.A.
- Independent Director
- 48.04万
- David E.I. Pyott, M.B.A.,M.D.
- Independent Director
- 47.04万
- Dr. Elaine J. Heron,PhD
- Independent Director
- 48.64万
- Mark J. Alles
- Independent Director
- 48.39万
- Dr. Maykin Ho, PhD
- Independent Director
- 47.39万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅